Key takeaways: What should be considered when selecting an RTSM vendor?
Welcome to our new "Key takeaways" series where we provide key insights from relevant articles about the industry. Today, we share the takeaways from a publication by our colleague David Shuford, a Principal Solutions Consultant. You can access the original article here: https://blogs.oracle.com/health-sciences/post/what-should-be-considered-when-selecting-an-rstm-vendor.
What should be considered when selecting an RTSM vendor?
In the context of clinical trials, selecting a vendor for an RTSM system is a critical decision that can impact the success of the study.
The author highlights the importance of choosing a partner that is committed to customer success and a technology that can support business growth. This means selecting a vendor with experience providing RTSM services, investing in technology over services to support scalable growth, and offering a mature RTSM tool that can support a wide variety of clinical trial protocols and drug supply management scenarios.
Additionally, the author notes that as the market for RTSM systems matures, vendors with configurable, scalable technology will have an advantage over those that rely on services. This is because configurable platforms increasingly rely on technology, rather than services, to ensure customer success.
Overall, selecting the right technology and partner for an RTSM system is imperative to ensure the success of a clinical trial, whether it's for a single trial or a program of trials. Factors to consider include vendor experience, technology investment, scalability, and quality and risk. By carefully considering these factors, businesses can select a vendor that can support their growth and provide long-term value.
If you're interested in learning more about Oracle's RTSM solution, we invite you to join one of our free training sessions. You can find the schedule by clicking here.